Bioceres Crop Solutions' Q1 revenue misses estimates

Reuters11-13
<a href="https://laohu8.com/S/BIOX">Bioceres Crop</a> Solutions' Q1 revenue misses estimates

Overview

  • Bioceres fiscal Q1 revenue declines 17% yr/yr, missing analyst expectations

  • Adjusted EBITDA for fiscal Q1 rises 61%, beating analyst expectations

  • Company focuses on margin expansion and cost discipline amid revenue decline

Outlook

  • Company prioritizes strengthening capital structure and financial flexibility

Result Drivers

  • REVENUE DECLINE - Co attributes 17% revenue decline to strategic shift away from low-margin sales and timing issues in Latam markets

  • MARGIN EXPANSION - Gross margin increased from 40% to 47% due to a more profitable product mix

  • WORKING CAPITAL IMPROVEMENT - Co reports improved working capital efficiency despite seasonally high needs

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Miss

$77.50 mln

$90.23 mln (4 Analysts)

Q1 Adjusted EBITDA

Beat

$13.60 mln

$11.02 mln (3 Analysts)

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the agricultural chemicals peer group is "buy."

  • Wall Street's median 12-month price target for Bioceres Crop Solutions Corp is $5.00, about 61.4% above its November 11 closing price of $1.93

Press Release: ID:nBw66KzD0a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment